Vapreotide
Somatostatin analog for esophageal varices and GI bleeding. Potent vasoconstrictive and antisecretory properties for acute hemorrhage control in portal hypertension.
Vapreotide (also known as RC-160 or BMY-41606) is a synthetic cyclic octapeptide analogue of somatostatin, a naturally occurring peptide hormone that inhibits the secretion of growth hormone and various other hormones. Structurally engineered with two D-amino acids (D-Phe at position 1 and D-Trp at position 4) and a Cys2-Cys7 disulfide bridge, vapreotide exhibits significantly enhanced metabolic stability and receptor selectivity compared to native somatostatin.
| Parameter | Specification |
| CAS | 103222-11-3 |
| Molecular Formula | C₅₇H₇₀N₁₂O₉S₂ |
| Molecular Weight | 1131.37 g/mol |
| Category | Oncology/Endocrine |
| Purity | ≥99% |
| Status | GMP-compliant, FDA-ready |
| Applications | Esophageal varices, GI bleeding, portal hypertension, pancreatitis |
| CAS | 103222-11-3 |
|---|---|
| Applications | Esophageal Variceal Bleeding, GI Bleeding, Somatostatin Analog |
Related products
-
Semaglutide
CAS: 910463-68-2Applications: cardiovascular risk reduction, obesity management, Type 2 diabetes -
Orforglipron
CAS: 2212020-52-3Applications: obesity management, Oral GLP-1 Development, Type 2 diabetes -
Pramlintide
CAS: 196078-30-5 -
Apraglutide
CAS: 1295353-98-8Applications: GLP-2, Intestinal Repair, Mucosal Growth, Short Bowel Syndrome